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Abstract
Background: Dopamine is an important neurotransmitter involved in reward mechanism in the brain and thereby
influences development and relapse of alcohol dependence. The dopamine D2 receptor (DRD2) gene on
chromosome 11 (q22-q23) has been found to be associated with increased alcohol consumption through
mechanisms involving incentive salience attributions and craving in alcoholic patients. Therefore, we investigated
the association of three single nucleotide polymorphisms (SNP) in DRD2 gene with alcohol dependence in the
north Indian subjects.
Methods: In a retrospective analysis, genetic association of three polymorphisms from DRD2 gene with alcohol
dependence was investigated using a case-control approach. Alcohol dependence was determined by DSM-IV
criteria and a total of 90 alcoholics and 60 healthy unrelated age-matched control subjects were recruited. Odds
ratio and confidence interval was calculated to determine risk conferred by a predisposing allele/genotype/
haplotype. Logistic regression analysis was carried out to correlate various clinical parameters with genotypes, and
to study pair-wise interactions between SNPs.
Results: The study showed a significant association of -141C Ins allele and a trend of association of TaqI A1 allele
of DRD2 with alcohol dependence. Haplotype with the predisposing -141C Ins and TaqI A1 alleles (-141C Ins-A-A1)
seems to confer ≈ 2.5 times more risk to develop alcohol dependence.
Conclusions: The study provides preliminary insight into genetic risk to alcohol dependence in Indian males. Two
polymorphisms namely, -141C Ins/Del and TaqI A in DRD2 gene may have clinical implications among Indian
alcoholic subjects.
Background
Alcohol dependence (AD) is a common but complex
trait with an estimated 6.5% lifetime prevalence in the
general population. Demographic data indicating higher
concordance rate for monozygotic twins when compared
with dizygotic twins suggest an important genetic con-
tribution to the pathogenesis of alcohol dependence [1].
Approximately 50-60% of the population variance in
alcohol dependence is accounted for by genetic factors
[2], but this influence is almost certainly due to the
combined effects of multiple genes, each exerting a
small individual effect and interacting with other genes
and environment [3].
The central dopamingeric system is widely considered
to play a crucial role in development of dependence to a
range of psychoactive substances including opiates,
cocaine, nicotine and alcohol [4-6]. The dopaminergic
system influences/regulates brain reward mechanism
[7,8] and is considered a strong candidate for alcohol
dependence. Alcohol, by stimulating dopamine recep-
tors, promotes dopamine release in the ventral striatum
leading to increased alcohol consumption through
mechanisms involving incentive salience attributions
and craving [9]. Clinical investigation involving analysis
of receptor density and function has implied that dopa-
mine D2 receptor (DRD2) density and function being
lower among alcoholics may be responsible for craving
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tide polymorphisms (SNPs), in dopaminergic pathway
genes has shown that inheritance of different SNPs can
increase or decrease the risk of alcoholism [10]. Conse-
quently, in several populations world over, genetic asso-
ciation studies have been carried out to determine
polymorphisms in genes encoding dopaminergic system
and susceptibility to alcohol dependence [11-15]. Pre-
vious genetic association studies of the dopamine recep-
tors (D1-D5) and transporter protein (DAT) have
indicated that DRD2 is involved in susceptibility to alco-
holism [16]. Presence of such clinical and genetic evi-
dences has implicated DRD2 gene polymorphisms as
strong candidates for alcoholism and therefore, they
have been most widely studied.
Since 1990, many studies have addressed possible
association of DRD2 polymorphism with alcoholism.
However, findings of these studies have largely remained
controversial. Inconsistent results have been explained
in terms of DRD2 mediated “reward deficiency” syn-
drome, and/or population stratification bias [17]. Most
of the positive findings are related to European or Eur-
opean American populations where as studies in Atayal
natives of Taiwanese populations have generally been
negative [18]. The DRD2 gene has three most com-
monly investigated polymorphisms (-141C Ins/Del, TaqI
B and TaqI A) and the results are equivocal for their
association with alcohol dependence [11,12]. The pro-
moter polymorphism (-141C Ins/Del, rs1799732) of the
DRD2 gene involving the insertion (Ins)/deletion (Del)
of a cytosine is related to receptor density [19]. SNP
TaqI B being closer to the regulatory and structural
coding regions (5’ region) of the gene [20] is considered
to play important role in transcription regulation. TaqI
A SNP is regarded as the most dramatic polymorphism
of DRD2 for its highly inconsistent association with AD.
The A1 allele of TaqI A SNP has been found to be asso-
ciated with low D2 dopamine receptor availability in the
striatum [21]. Recently, it has become evident that the
TaqI A polymorphism previously considered to be pre-
sent in 3’ UTR of DRD2 is actually located in a nearby
novel gene (in reverse orientation) named ankyrin repeat
and kinase domain containing (ANKK1) where it causes
a missense substitution [22]. TaqI A SNP of the ANKK1
gene is associated with increased striatal activity of aro-
matic L-amino acid decarboxylase, the final enzyme in
the biosynthesis of dopamine [22].
India, representing 1/6
th of the world population, has
sudden surge in alcohol dependence and related pro-
blems. As per the estimates of the National Survey,
about 21% of male adult population could be described
as ‘Current User’ (defined as consumption at least once
in preceding one month), which translates into about 62
million people, out of which about 17% are dependent
users [23]. However, only one genetic association study
to unravel genetic predisposition in Indian alcoholic
population has been carried out to date [24]. In view of
the paucity of Indian data on genetic polymorphism of
alcohol dependence, we aimed to investigate the associa-
tion of DRD2 gene polymorphisms in alcohol dependent
subjects of north Indian origin.
Methods
Study population
Ethical committee clearance from the All India Institute
of Medical Sciences (AIIMS) was obtained before initia-
tion of the study. A written informed consent was
obtained prior to recruitment of case and control sub-
jects. The process of clinical assessment was carried out
by qualified psychiatrist. One hundred and forty male
alcohol dependent subjects attending the out patient
department (OPD) at National Drug Dependence Treat-
ment Centre, All India Institute of Medical Sciences
(AIIMS) were screened. Out of these, 37 were polysub-
stance users and 13 had co-morbid depression/anxiety/
or schizophrenia, and therefore, were excluded from the
study. Remaining 90 unrelated outpatients with alcohol
dependence, in the age range of 18-60 years, were
enrolled as cases (AD). A total of 60 unrelated healthy
male employees of the hospital, without any history of
substance use (except nicotine) were included as con-
trols (C). Since nicotine use is widely prevalent among
males in India, neither case nor controls were excluded
on the basis of their nicotine use. All individuals
regarded themselves to be of north Indian origin. Diag-
nosis of alcohol dependence was determined by experi-
enced psychiatrists using the DSM-IV criteria
(American Psychiatric Association, 1994; [25]). The
study was conducted in accordance with worldwide
good-clinical-practice (GCP) standards and confirmed to
acceptable ethical standards as outlined by local require-
ments and the Declaration of Helsinki (World Medical
Association, 1989).
All patients were assessed for alcohol use parameters
using AUDIT [26], and a semi-structured questionnaire.
The semi-structured questionnaire included items on
clinical details like ethnicity, family history, age at first
use of alcohol, quantity of alcohol consumption (g/day),
duration of alcohol use, duration of alcohol dependence,
age at onset of dependence, presence/absence of delir-
ium and any other psychiatric or physical illness. The
same semi-structured questionnaire was used for assess-
ment of the control population as well. The assessments
also included liver function tests (LFT) such as serum
proteins, albumin, bilirubin, glutamic oxaloacetic transa-
minase (SGOT) and glutamic pyruvic transaminase
(SGPT), gamma-glutamyltransferase (GGT), and mean
corpuscular volume (MCV). LFT were estimated on
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Mannheim kits (Germany).
Genetic Analysis
DNA was isolated from the lymphocytes using the con-
ventional phenol-chloroform organic extraction method
[27] and used for genetic analysis. Three SNPs were
selected from the DRD2 locus based on prior published
association reports, information content, minor allele
frequency (MAF), linkage disequilibrium (LD) structure,
and validation evidence. SNP genotyping was done
using polymerase chain reaction (PCR)-restriction frag-
ment length polymorphisms (RFLP) approach following
previously published method [28,29]. The digested PCR
products were resolved on 2-3% agarose gel stained with
ethidium bromide. Genotypic profiles obtained for each
of the polymorphisms are presented in Table 1.
Position of the three SNPs studied in DRD2 along with
their identification number is indicated below
-141C Ins/Del, promoter (rs1799732); G>A, TaqI B, 1
kb upstream from exon 2 (rs17294542); and T>C, TaqI
A, 10 kb downstream from exon 8 (rs1800497).
Statistical Analysis
Comparison of all clinical variables between alcohol
dependent (AD) and control (C) subjects was carried
out by c
2 test for nominal variables or student’st - t e s t
for continuous variables. Continuous variables with
skewed distribution were compared by Mann Whitney’s
U test. Hardy-Weinberg equilibrium (HWE) was tested
for each of the genetic marker. Allelic and genotypic
associations of SNPs were evaluated by Pearson’s c
2 test
followed by odds ratio and 95% CI computation. Fisher’
exact test was applied for SNPs having cell value less
than 5 for any one (out of three) genotypes. Power of
the sample size for each of the SNPs was calculated
using PAWE software version 1.2 [30,31]. Haplotype
analysis was performed using PHASE-standard analysis
version 2.0.2 [32,33]. Chi-square values were derived
from a series of 2 × 2 contingency tables based on the
frequency of each haplotype versus all others between
the AD and the control groups. Multiple logistic regres-
sion (MLR) analysis were carried out to correlate var-
ious clinical parameters with genotypes and to study




A comparison of demographic and clinical characteris-
tics between cases and controls are presented in Table
2. As can be seen in the table, on almost all demo-
graphic parameters, the control group was largely simi-
lar to the AD group. However, much larger proportion
of AD subjects had education up to primary school (i.e.
five years of formal schooling) only. The values for var-
ious clinical parameters such as AUDIT score, alcohol
intake (g/day) SGOT, SGPT, GGT, cholesterol, and tri-
glycerides (TG)] were significantly higher (P < 0.01)
among AD (cases) as compared to the control group.
Genetic analysis
A l lt h et h r e eS N P sa n a l y z e di nt h es t u d yw e r ei nH W E
in the base line control population. No significant pair-
wise linkage disequilibrium was observed between the
three polymorphisms. Allele and genotype frequencies
of SNPs in DRD2 and their association status with AD
are presented in Table 3.
Of the three polymorphisms analyzed in DRD2 gene,
significant allelic and genotypic association of -141C
Ins/Del SNP was observed with alcohol dependence.
SNP TaqI B did not show any allelic or genotypic asso-
ciation. For TaqI A SNP, genotype Taq A1A1 was pre-
sent in negligible frequency. Categorical analysis showed
significant association of Taq A1/A2 genotype (Fisher’s
exact p < 0.05) with alcohol dependence. In addition, a
trend towards association of allele TaqI A1 with AD
was also found (Table 3).
Significantly associated haplotypes of DRD2 gene pre-
sent in AD subjects are shown in Table 4. Two (-141C
Ins-A-A1, and -141C Del-A-A2) out of eight possible
haplotypes in these cases were significantly associated
Table 1 Genotypic profiles obtained for DRD2 polymorphisms




Ins C = 124, 32






TaqI A F:5’CCGTCGACGGCTGGCCAAGTTGTCCA 3’
R:5’CCGTCGACCCTTCCTGAGTGTCATCA3’
58°C/TaqI
T (A1) = 310
C (A2) = 180,130
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to AD (Table 4).
A combined analysis involving genetic and crucial
clinical/laboratory parameters (SGOT, SGPT, GGT, and
alcohol consumed/day) indicated that the sub-group of
AD patients with -141C Ins/Ins genotype (of -141C Ins/
Del polymorphism) had significantly higher values (P <
0.01) of SGOT, SGPT, and GGT as compared to those
with -141C Ins/Del and -141C Del/Del genotypes.
To assess synergistic effect of various clinical and gen-
otypic parameters (analyzed in this study), multiple
logistic regression analysis (MLR) was carried out. Dis-
ease status was taken as the dependent parameter, and
genotypes, alleles (-141C Ins/Del, TaqI B, TaqI A) and
clinical parameters were taken as the independent vari-
ables. A significant association of SNP -141C Ins/Del of
DRD2 gene (P < 0.05; OR 0.19, 95%CI 0.06-0.6) was
seen with AD. Further categorical analysis identified
-141C Ins allele (P < 0.05; OR 1.81, 95%CI 1.03-3.19) to
be predisposing to AD. No significant interaction
between any of the polymorphisms/genes was observed
when pair-wise interactions between different poly-
morphisms were carried out by multiple logistic regres-
sion analysis.
Discussion
In relation to alcohol dependence, the research provides
unambiguous evidence that genes and their polymorph-
isms play an important role in its development [34].
Alcohol increases synaptic dopamine, which reinforces
self administration. In the ventral striatum and particu-
larly in the nucleus accumbens, different drugs of abuse
stimulate dopamine release thereby reinforcing drug
consumption. The down regulation of dopamine D2
receptors in these areas of the brain have been asso-
ciated with alcohol craving and an increase in the pro-
cessing of alcohol-related stimuli in the medial
prefrontal cortex [9]. Dopamine D2 receptor gene
(DRD2) encodes a G protein-coupled receptor located
on post-synaptic dopaminergic neurons, which plays a
central role in reward-mediating mesocorticolimbic
pathways [20]. Possible association between polymorph-
isms at the DRD2 gene and alcohol dependence has
Table 2 Demographic and Clinical characteristics of the
study population presented as Mean ± SD
Characteristics AD (Case) Controls
Age (y) 36.75 ± 9.27 35.17 ± 11.59
Married 86% 80%
Employed 96% 100%
Education up to Elementary School
Only
37% 1%
Living with family 85% 82%
Age at first use of alcohol 19.89 ± 5.56 24.30 ± 6.28
Audit Score 32.12 ± 5.59 1.04 ± 1.58
Alcohol intake (g/day) 183.89 ±
104.54
2 ± 0.5
T.Bil. (mg/dl) 1.96 ± 0.78 0.7 ± 0.2
T.Prot. (g/dl) 7.02 ± 1.04 8.00 ± 0.76
Alb. (g/dl) 4.19 ± 0.54 4.52 ± 0.30
SGOT (U/l) 84.21 ± 27.76 27.02 ± 09.71
SGPT (U/l) 83.13 ± 26.29 28.30 ± 11.49
Chol. (mg/dl) 181.49 ± 53.11 132.62 ±
12.01
GGT (U/l) 210.02 ± 42.02 24.95 ± 11.88




Table 3 Allele and genotype frequencies of SNPs in DRD2 and their association status with AD
SNPs Genotypes Statistics Alleles Statistics Power (*G %)
-141C Ins/Del Ins/Ins Ins/Del Del/Del Ins Del
AD 0.61 0.32 0.07 c
2 = 11.0, P < 0.01 0.77 0.23 c
2 = 4.3, P < 0.05 62
Controls 0.57 0.16 0.27 0.65 0.35
TaqI B GG GA AA G A
AD 0.07 0.37 0.56 c
2 = 0.11, P = 0.94 0.25 0.75 c
2 = 0.12, P = 0.72 6
Controls 0.11 0.31 0.58 0.27 0.73
TaqI A A1A1 A1A2 A2A2 A1 A2
AD 0.04 0.45 0.51 Fisher’s exact test P < 0.05 0.27 0.73 Fisher’s exact test p = 0.08 16
Controls 0.07 0.30 0.63 0.22 0.78
*G: the power of SNP to detect association, calculated using PAWE software
Table 4 Significantly associated SNP haplotypes in DRD2
gene
aHaplotype C (120) AD (180) c
2 P O.R (95% CI)
-141C Ins-A-A1 13(0.11) 38 (0.21) 5.39 0.02 2.20 (1.19-4.33)
-141C Del-A-A2 12 (0.10) 06 (0.03) 5.67 0.01
b 0.31 (0.11-0.85)
aOrder of SNPs in the DRD2 haplotypes: -141C Ins/Del - G>A (Intron 1) - TaqI
A (Intron 7)
bSignificant after Bonferroni correction a = 0.01
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1990 [35].
The present study tested association of three poly-
morphisms -141C Ins/Del, TaqI B and TaqI A, present
at DRD2 gene locus with alcohol dependence in north
Indian subjects.
To the best of our knowledge, this study constitutes
the first association report with regard to the first two
SNPs (-141C Ins/Del, TaqI B in DRD2 gene) with alco-
hol dependence from India. Although, association of
TaqI A with AD has not been carried out in the north
Indian population by anyone to date, a study from south
India reported no association between TaqI A and alco-
holism [24].
The -141C Ins/Del polymorphism has been investi-
gated for its association with alcoholism in several stu-
dies across different populations [1,36,37], however, the
results are inconsistent. This promoter polymorphism
plays an important role in D2 receptor expression. An
in vitro analysis suggested that -141C Ins/Del poly-
morphism of DRD2 alters its transcriptional activity and
thus regulates the expression of DRD2 receptor [19]. An
imaging study carried out in healthy volunteers demon-
strated increased striatal receptor density in -141C Del
carriers [38]. In a genetic association study, Samocho-
wiec et al. (2000) suggested a possible role of -141C
Ins/Del SNP (in particular haplotypic combination, Ins/
G/A2) in German alcoholics [39]. However, in a family-
based case-control study of a Polish population, they
failed to replicate this finding [40]. Johann et al. (2005)
studied the association of a -141C deletion variant
(-141delC) of the DRD2 gene in well-characterized, pri-
mary chronic alcoholics of German descent and found
an excess of the -141delC alleles in alcoholics with a
paternal and grand-paternal history of alcoholism. They
concluded that though the -141delC variant of DRD2
might be a protective factor against the development of
withdrawal symptoms, it might also be a risk factor in a
highly burdened subgroup of alcoholics with a paternal
and grand-paternal history of alcoholism [41]. Signifi-
cant association of SNP -141C Ins/Del (P < 0.05; OR
0.19, 95%, CI 0.06-0.6) in DRD2 gene with alcohol
dependence followed by categorical analysis suggesting
-141C Ins allele to be predisposing to alcohol depen-
dence in the present study is in conformity with findings
of Konishi et al., which indicated that -141C Ins allele is
a genetic risk factor for alcoholism in Mexican-Ameri-
cans [36]. Thus a significant over representation of
-141C Ins allele in alcoholic subjects in our study may
be correlated with decreased DRD2 receptor density in
AD patients, which in turn stimulates craving - reward
pathway - thereby promoting alcohol dependence. How-
ever, this statement should be interpreted with caution
since Hirovonen et al., (2009) suggested that the -141C
Ins/Del genotype did not influence extrastriatal DRD2
binding potential using 3D-PET imaging in healthy male
controls [42]. Further, our results also suggest that pre-
sence of -141C Del/Del genotype confers protection
from AD and -141C Ins allele carriers are at higher risk
for developing AD as compared to -141C Del carriers.
As the power to of the sample size to detect association
of this SNP was moderate (G = 62%), the observed gen-
otypic and allelic association with AD needs to be inter-
preted cautiously.
SNP TaqI B is closer to the regulatory and structural
coding regions (5’ region) of the DRD2 and thus sup-
posed to play an important role in gene function [27]. It
has been rarely investigated for its association with AD.
Two studies [36,43] carried out in Mexican-American
population reported conflicting results with regard to
association of this polymorphism with AD. Our observa-
tion of no allelic or genotypic association of TaqI B
polymorphism with AD in north Indians concurs with
Konshi et al. [36] reporting no positive association of
TaqI B with AD in Mexican-Americans. However in a
subsequent study, the same group reported an associa-
tion of TaqI B polymorphism with early age of onset for
alcohol drinking in Mexican-Americans [43].
ANKK1 rs1800497, previously called “DRD2 TaqI A”,
is one of the most frequently studied polymorphisms in
DRD2 genetic studies. Neville et al. [44] determined that
the DRD2 TaqI A is actually located not within DRD2,
but rather within a protein-coding region, exon 8, of the
adjacent ANKK1 gene. Blum et al. [35] reported the pre-
sence of A1 allele of DRD2 receptor gene classifying
77% of alcoholics, demonstrating an association of A1
allele with alcoholism. Association studies of the DRD2
TaqI A1 allele and alcohol consumption have remained
ambiguous and controversial due to conflicting results
[45]. Although the DRD2 TaqI A polymorphism and
alcohol dependence have been studied extensively, it
emerged that this polymorphism may affect substrate-
binding specificity. It remains to be elucidated whether
the associations with TaqI A are due to its own func-
tionality or linkage disequilibrium with another DRD2
variation or with the ANKK1 gene [45]. Pohjalainen et
al. [21] reported an association between A1 allele and
low D2 receptor availability in healthy subjects indicat-
ing that A1 allele of the TaqI A polymorphism might be
in linkage disequilibrium with a mutation in the promo-
ter/regulatory gene that affects dopamine D2 receptor
expression. This was further correlated with risk confer-
ring nature of the A1 allele in subsequent association
studies in different populations like Caucasians, Han
Chinese, and Europeans [24]. However, few studies from
East Asian, European and Caucasian populations
reported negative association of TaqI A1 allele with
alcohol dependence [46]. Recently, Samochowiec et al.
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AD in a Polish population [40]. However, they observed
a statistically significant preferential A2 allele transmis-
sion in DRD2 TaqI A gene polymorphism in subgroups
of patients with early onset and withdrawal complica-
tions. Their results also suggested various subtypes of
alcohol dependence, which differ depending on their
genetic background and may confound association find-
ings [40].
Further, Laruelle et al. (1998) did not find association
between A1 allele and lower D2 receptor expression and
suggested that D2 receptors binding potential is not
affected by TaqI A polymorphism at the D2 receptor
gene [47]. Our observation of association of TaqI A is
due to significant excess of heterozygote Taq A1/A2
genotype in the AD population from north India which
could be attributed to yet unknown selection pressure.
However, a marginal association of allele TaqI A1 is in
concurrence with the meta-analysis carried out by
Munafo et al. where association of the DRD2 TaqI A
polymorphism with alcoholism suggest that A1 allele
confers modest increase in risk [48]. Considering this
background, the association of TaqI A1 allele with AD
i nt h ep r e s e n ts t u d yc o u l db ed u et ot h ea l t e r e dD 2
receptor expression and reward mechanism in alcohol
dependent subjects. Since the power of the sample size
to detect association of this SNP was low (G = 16%), the
observed association (of this SNP with AD) should not
be over-interpreted.
Our observation of A2/A2 genotype being most com-
mon in North Indian population is in concurrence with
Caucasian population where an excess of A2 homozy-
gotes has been reported [49]. The A1 allele frequency
ranges between 0.06 and 0.18 in populations with Eur-
opean ancestry, while a significantly higher frequency
(0.7) is seen in native South American populations [24].
In the present study, allele frequency (0.22) observed for
A1 allele is closer to European population whereas the
allele frequency observed in the south Indian population
(0.42) is similar to reports from south East Asian popu-
lations with allele frequencyo f0 . 4 5[ 2 4 ] .T h eo b s e r v e d
difference in allele frequencies between north Indian
and south Indian population is due, in part, to the many
different waves of immigrants that have influenced the
genetic structure of India. The Indo-European (IE) and
Dravidian (DR) groups have been the major contributors
to the development of Indian culture and society. People
from southern part of India have Dravidian background,
and those form northern part have Indo-European (Cau-
casoid) background [50].
Results of independent association of SNPs were repli-
cated in haplotypic association. As expected haplotype
containing -141C Ins and TaqI A1 alleles was found to
be predisposing to alcoholism and conferred ≈ 2.5 times
risk to patients with this haplotypic combination (-141C
Ins-A-A1). On the other hand haplotypic combination
with -141C Del and Taq A2 alleles (-141C Del-A-A2)
seems to confer protection against alcoholism. Thus,
our result of haplotypic association (-141C Ins-A-A1) is
in partial concurrence with German population where
haplotype Ins/A2 causes predisposition to severe alco-
holism [36]. Inconsistency between our and the previous
report [36] could be attributed to population specific
differences in genetic structure.
SGOT, SGPT, and GGT are markers of alcohol
related liver dysfunction. Heavy drinking causes acetal-
dehyde toxicity leading to liver damage. A sub-analysis
based on genotypic constitution with regard to -141C
Ins/Del SNP revealed significant alteration in liver func-
tions (as indicated by higher SGOT, SGPT and GGT
values) among patients with -141C Ins/Ins genotype.
We propose that this finding of association of -141C
Ins/Del SNP with liver dysfunction among alcoholics
should be explored further, though in this study it may
be a purely chance finding.
Conclusions
Two polymorphisms namely, -141C Ins/Del and TaqI A
in DRD2 seem to have clinical implications in the devel-
opment of alcoholism. However, our results have to be
viewed in the perspective of potential limitation posed
by small sample size and it warrants replication in larger
sample sets.
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